The significance of fibronectin detection in hepatofibrosis

doi:10.3969/j.issn.1673-8640.2014.04.008

Abstract

Abstract:

Objective　To investigate the change of serum fibronectin （Fn） level in patients with hepatopathy and the significance of Fn in hepatofibrosis. Methods　Serum Fn levels in patients with hepatopathy and healthy controls were determined. Serum total bile acid （TBA） and albumin（Alb） were determined， and the results were analyzed comparatively. Results　Serum Fn levels in patients with oxyhepatitis and liver cancer had no statistical significance with those in healthy controls with statistical significance（P>0.05）. Serum Fn levels in patients with chronic moderate hepatitis， chronic severe hepatitis and cirrhosis were lower than those in healthy controls with statistical significance（P<0.05）. Serum Fn levels in patients with cirrhosis were lower than those in other patients with hepatopathy（P<0.05）. Serum Fn levels in patients with alcohol cirrhosis and virus cirrhosis had no statistical significance（P>0.05）. Serum Fn levels in cirrhosis patients with complications，such as peritonitis， hemorrhage of digestive tract and hypersplenia， decreased significantly than those without complications（P<0.05）. Serum Fn and TBA in healthy controls and patients with oxyhepatitis and liver cancer had no correlation （P>0.05）， and had negative correlation between patients with chronic moderate hepatitis， chronic severe hepatitis and cirrhosis（r=-0.593，－0.677 and －0.714， P<0.05）. Serum Fn had no correlation with Alb （P>0.05）. Conclusions　Serum Fn can reflect the function of hepatocyte in a certain extent， and has certain reference significance in the diagnosis of hepatofibrosis especially cirrhosis and cirrhosis with infection. The diagnostic accuracy and reliability of Fn determination with TBA and Alb can be obviously improved.

Key words: Fibronectin, Hepatofibrosis, Cirrhosis, Total bile acid, Albumin

CLC Number:

R446.11

YANG Jingjing，JIANG Hongmin，TANG Aiguo.. The significance of fibronectin detection in hepatofibrosis[J]. , 2014, 29(4): 331-336.

References

[1] 中华医学会传染病与寄生虫病学分会,中华医学会肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62.
[2] 石法武.肝炎、肝硬化及肝癌治疗的误区-如何阻断肝炎、肝硬化、肝癌链条[M].西安:人民军医出版社,2008:1-28.
[3] 韩捷,解慧,葛进,等.血清Fn、HA和LN与肝纤维化的关系[J].第四军医大学学报,1997,18(6):595-596.
[4] 郑利平,潘爱萍.乙肝患者血清学标志物与肝纤维化的关系[J].广东医学,2008,29(7): 1143-1145.
[5] Wight TN,Potter-Perigo S.The extracellular matrix: an active or passive player in fibrosis[J].Am J Physiol Gastrointest Liver Physiol, 2011, 301(6): G950-G955.
[6] 倪童天,陆伦根.慢性乙型肝炎肝纤维化临床诊断和治疗进展[J].实用肝脏疾病杂志,2010,13(2):142-145.
[7] 刘娓娓,顾文君,沈锡中.血清生化指标对慢性乙型肝炎肝纤维化及炎症程度的诊断价值[J].中国临床医学,2005,12(1):65-66.
[8] Poynard T, Aubert A, Bedossa P, et al. A simple biological index for detection of alcoholic liver disease in drinkers[J].Gastroenterology,1991,100(5 Pt 1):1397-1402.
[9] 黄妩姣,李涛,周罗晶,等.丙型肝炎患者血清肝功能与肝纤维化的相关性[J].广东医学,2010,31(24):3218-3219.
[10] 晏晓敏,邹东文,刘海娟.乙型肝炎患者血清纤维结合蛋白检测的临床意义[J].实用预防医学,2006,13(4):1045-1046.
[11] 干振若,于文彬,苏明权,等.实用检验医学手册[M].第2版.北京:人民军医出版社,2002:746-747.
[12] Saba TM, Jaffe E. Plasma fibronectin (opsonic glycoprotein):its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function[J].Am J Med,1980,68(4):577-594.
[13] 朱忠勇.实用医学检验学[M].北京:人民军医出版社,1992:807.
[14] Matsuda M,Yamanaka T,Matsuda A.Distribution of fibronectin in plasma and liver in liver diseases[J].Clin Clim Acta,1982,118(2-3):191-199.
[15] 朱国静,范宗滂.肝纤维化发病机理、诊断及治疗的进展[J].临床肝胆病杂志,1993,9(4):178-181.
[16] 潘兆随,田树堂,唐保禄,等.肝炎患者血浆纤维结合蛋白水平的观察[J].临沂医专学报,1990,12(3):207-210.
[17] 郑晓丰.m-AST、RBP、PA、ADA和FN在肝脏疾病诊断中的临床评价[J].检验医学,2009,24(12):886-888.
[18] 巨平,赵文学,程训明,等.肝病患者血浆纤维结合蛋白的测定[J].陕西医学杂志,1992, 21(7): 55-56.
[19] Foster PN, Bowen M, Howdle PD, et al. Low fibronectin in portal hypertension[J]. Digestion,1983,28(2):122-124.
[20] 周新,府伟灵.临床生物化学与检验[M].第4版.北京:人民卫生出版社,2008:13-14.
[21] 张依军.肝病患者血清胆碱酯酶活性与白蛋白水平检测的意义探讨[J].中国误诊学杂志,2007,7(30):7243-7244.
[22] 杨旭,雷建华,张永红,等.血清总胆汁酸测定的意义及其局限性[J].中华内科杂志,2001,40(1): 16-18.
[23] Bahar RJ, Stolz A. Bile acid transport[J]. Gastroenterol Clin North Am,1999, 28(1): 27-58.
[24] Pennington CR, Ross PE, Bateson MC, et al. Serum bile acids in patients with hyperlipidaemia[J].J Clin Pathol,1978,31(1):58-62.
[25] Barnes S, Gallo GA, Trash DB, et al.Diagnostic value of serum bile acid estimations in liver disease[J].J Clin Pathol,1975, 28(6): 506-509.
[26] 姚勤,沈启刚,陈密.血清胆碱酯酶、前白蛋白和总胆汁酸与肝硬化Child-Pugh分级的关系[J]. 世界感染杂志,2005,5(2):132-133.
[27] 杜红缨.肝硬化患者血清总胆汁酸水平与Child-Pugh分级的关系[J].淮海医药,2002, 20(6):466-467.